Early coronavirus vaccine results are encouraging, maker says

The vaccine generated antibodies similar to those seen in people who have recovered from COVID-19 in study volunteers.

SHARE Early coronavirus vaccine results are encouraging, maker says
merlin_91140997.jpg

The vaccine by Moderna Inc., generated antibodies similar to those seen in people who have recovered from COVID-19 in study volunteers.

Getty

CAMBRIDGE, Mass. — An experimental vaccine against the coronavirus showed encouraging results in very early testing, triggering hoped-for immune responses in eight healthy, middle-aged volunteers, its maker announced Monday.

The vaccine by Cambridge, Massachusetts-based Moderna Inc., generated antibodies similar to those seen in people who have recovered from COVID-19 in study volunteers who were given either a low or medium dose.

In the next phase of the study, led by the U.S. National Institutes of Health, researchers will try to determine which dose is best for a definitive experiment that they aim to start in July.

The vaccine seems safe so far, the company said. A high dose version is being dropped after spurring some short-term side effects.

Worldwide, about a dozen vaccine candidates are in the first stages of testing or nearing it.

The Latest
College student’s mom would prefer that the young woman not accompany him to every family event at home and on campus.
“I feel like I [have his support], but I don’t really focus on that,” Grifol said. “I’m the manager right now. And I’ll do it for as long as they want me to do this.”
Albert Ruddy produced more than 30 movies, from the “Godfather” and “Million Dollar Baby” to “Cannonball Run II” and “Megaforce,” nominees for Golden Raspberry awards for worst movie of the year.
A late-game surge fueled by their defense cut the Sky’s deficit to five, but poor late-game execution allowed the Storm to close it out.